287 related articles for article (PubMed ID: 19050206)
1. Botulinum toxin for urogenital conditions.
Eccleston KJ; Woolley PD
Int J STD AIDS; 2008 Dec; 19(12):797-9. PubMed ID: 19050206
[TBL] [Abstract][Full Text] [Related]
2. Other noncosmetic uses of BOTOX.
Verheyden J; Blitzer A
Dis Mon; 2002 May; 48(5):357-66. PubMed ID: 12195265
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Toxin A in bruxers. One year experience.
Redaelli A
Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A and tension-type headache.
Prescrire Int; 2013 May; 22(138):133. PubMed ID: 23819183
[No Abstract] [Full Text] [Related]
6. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
Chankrachang S; Arayawichanont A; Poungvarin N; Nidhinandana S; Boonkongchuen P; Towanabut S; Sithinamsuwan P; Kongsaengdao S
Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
[TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin in urology. Indications and results].
Schurch B; Reitz A
Urologe A; 2004 Nov; 43(11):1410-5. PubMed ID: 15309305
[TBL] [Abstract][Full Text] [Related]
8. Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections.
Pascali MP; Mosiello G; Boldrini R; Salsano ML; Castelli E; De Gennaro M
J Urol; 2011 Jun; 185(6 Suppl):2552-7. PubMed ID: 21527192
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin for chronic migraine.
Med Lett Drugs Ther; 2011 Jan; 53(1356):7-8. PubMed ID: 21252842
[No Abstract] [Full Text] [Related]
10. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
Wynn RL
Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
[No Abstract] [Full Text] [Related]
11. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B
Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
[No Abstract] [Full Text] [Related]
14. Botulinum toxin type A in children. New indication for limb spasticity.
Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
[No Abstract] [Full Text] [Related]
15. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
[No Abstract] [Full Text] [Related]
16. Botulinum toxin: clinical techniques, applications, and complications.
Stephan S; Wang TD
Facial Plast Surg; 2011 Dec; 27(6):529-39. PubMed ID: 22205526
[TBL] [Abstract][Full Text] [Related]
17. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
[TBL] [Abstract][Full Text] [Related]
18. Writer's block: "texting" impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis.
Lehman JS
Arch Dermatol; 2011 Jun; 147(6):752. PubMed ID: 21690551
[No Abstract] [Full Text] [Related]
19. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
De Laet K; Wyndaele JJ
Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disorders.
O'Leary M; Dierich M
Urol Nurs; 2010; 30(4):228-34. PubMed ID: 20949807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
